- ʻO nā malihini kipa piha ʻia mai India e koi mau e hele i 10-lā COVID-19 quarantine.
- Ua hoʻomohala pū ʻia ka lāʻau lapaʻau Covishield e ke Kulanui ʻo Oxford a me AstraZeneca a hana ʻia e Serum Institute o India.
- ʻAʻole koi ʻia nā poʻe Britons i ka UK me nā jab i hana ʻia e India e quarantine.
Ua hoʻolaha aku ke Aupuni Hui Pū ʻIa e hoʻomaha ia i ka COVID-19 pandemi curbs no nā malihini kipa haole piha i hoʻomaʻamaʻa ʻia e hoʻomaka ana i ka mahina mua.
Akā ʻo ka papa inoa o nā ʻāina me nā lāʻau āpau i ʻae ʻia ʻaʻole i hoʻokomo ʻo India, ʻoiai ka ʻāina e hoʻohana nei i kahi mana o ka lāʻau AstraZeneca i hoʻomohala ʻia ma UK, a he kumu ia e hōʻalulu ai i ka politika a me nā hoʻoweliweli o ka hoʻopaʻi pānaʻi ʻana mai nā luna India.
ʻO ka lāʻau lapaʻau Covishield, hoʻomohala pū ʻia e ka Oxford University a AstraZeneca a hana ʻia e ka Pune-based Serum Institute of India, ʻaʻole i ʻike ʻia e ka United Kingdom ma lalo o ke kānāwai hou me ke ʻano like o ka ʻenehana i nā kaupaona i hāʻawi ʻia i nā miliona o ka poʻe Britain.
ka AstraZeneca hana ka lāʻau lapaʻau i ka hapa nui o nā mahele i hāʻawi ʻia i nā Indians a hiki i kēia lā. Ua lawe ka helu ʻuʻuku i kahi lāʻau āpau ʻōiwi i hoʻomohala ʻia e Bharat Biotech, ka mea hoʻohana ʻole ma UK.
Ua koi aku ke kuhina nui o ʻInia i nā mana aupuni o Beritania no kahi "hoʻonā mua o ka pilikia quarantine" me nā India e kipa ana i ka ʻO Kingdo UnitedKe koi ʻia nei wau e quarantine inā ua hoʻomaʻamaʻa piha ʻia lākou.
Nā kānāwai komo hou, i hoʻomaka i loko o ʻOkakopa, ua huhū nā Indians he nui, ka poʻe i kuni i ka hoʻoholo ma ke ʻano he hoʻokae. ʻAʻole koi ʻia nā poʻe Britons i ka UK me nā jab i hana ʻia e India e quarantine.
"Koi ʻia ka hoʻonā mua ʻana o ka pilikia quarantine no ka hoihoi pū," i ʻōlelo ai ke Kuhina Nui ʻo Subrahmanyam Jaishankar i kahi leka i kēia lā ma hope o ka hui ʻana me kāna hoa Pelekane ʻo Liz Truss ma New York, kahi e hele pū ana lāua ʻelua i ka United Nations General Assembly.
ʻO ka neʻe ʻana o Pelekane hiki ke alakaʻi ʻia i ka hoʻopaʻi hou mai New Delhi, me kahi luna aupuni India e ʻōlelo nei e lawe paha i nā ʻāpana pānaʻi inā ʻaʻole i hoʻoholo koke ʻia ka hihia.
"ʻO ke kumumanaʻo nui, eia kahi lāʻau lapaʻau - Covishield - kahi huahana laikini o kahi hui UK i hana ʻia ma India kahi a mākou i hoʻolako ai i ʻelima mau miliona i UK no ke noi a ke aupuni," ʻO ke Kakauolelo ʻ Foreigniwi ʻo Harsh Vardhan Shringla. haʻi aku i ka poʻe nūpepa ma New Delhi.
Ke kāhea nei i ka hoʻomaopopo ʻole ʻia o Covishield "kahi kulekele hoʻokae", ua ʻōlelo ʻo ia e hoʻomaka ana nā kūkākūkā ʻana me UK no nā koi hou.
"Akā inā ʻaʻole mākou e leʻaleʻa aia mākou i loko o kā mākou kuleana e hoʻokau i nā hana pānaʻi."
Ua ʻōlelo ke Komikina Nui Pelekane ma New Delhi e hana pū ana ʻo UK me ʻInia e hoʻonā i ka pilikia.
ʻO ke kānāwai, kauoha ʻia he 10 mau lā o ka hoʻokaʻawale iā ʻoe iho no nā mea huakaʻi e hōʻea ana mai India mai, pili pū kekahi i nā ʻāina ʻē he nui e hoʻohana ana iā Covishield, e like me ka hapa nui o nā poʻe ʻApelika.
He aha e lawe ʻia mai kēia ʻatikala:
- “The basic issue is that, here's a vaccine – Covishield – which is a licensed product of a UK company manufactured in India of which we have supplied five million doses to the UK at the request of the government,” India's Foreign Secretary Harsh Vardhan Shringla told reporters in New Delhi.
- The Covishield vaccine, developed jointly by the Oxford University and AstraZeneca and manufactured by Pune-based Serum Institute of India, is not recognized by the United Kingdom under the new rule despite being technically identical to the doses given to millions of Britons.
- Akā ʻo ka papa inoa o nā ʻāina me nā lāʻau āpau i ʻae ʻia ʻaʻole i hoʻokomo ʻo India, ʻoiai ka ʻāina e hoʻohana nei i kahi mana o ka lāʻau AstraZeneca i hoʻomohala ʻia ma UK, a he kumu ia e hōʻalulu ai i ka politika a me nā hoʻoweliweli o ka hoʻopaʻi pānaʻi ʻana mai nā luna India.
